(Reuters) - The biopharmaceutical company cut its work force to 8 employees from 33 and plans to further reduce its current work force in the near future.
Point Therapeutics plans to replace its employees with a more variable cost-effective consulting team to help the company as it seeks a buyer or partner for its technology and related intellectual property and other assets, in bankruptcy or otherwise.
Read more at Reuters.com Bonds News
Point Therapeutics plans to replace its employees with a more variable cost-effective consulting team to help the company as it seeks a buyer or partner for its technology and related intellectual property and other assets, in bankruptcy or otherwise.
Read more at Reuters.com Bonds News
No comments:
Post a Comment